Tempus Ai: Clinical Trials

2 trials sponsored by Tempus Ai, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Tempus Ai: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4
Pegylated IFN- alpha 2b, Ribavirin - Hepatitis C
Phase 4CompletedAin Shams University2802002-04-012008-02-26
Timing and Duration of Acute Hepatitis C Treatment
Pegylated interferon alpha 2, Ribavirin - Hepatitis C
Phase 4CompletedAin Shams University1802002-01-012006-09-11

Conditions studied

Hepatitis C (2)  ·  Hepatitis C, Chronic (1)

Interventions

Ribavirin (2)  ·  peginterferon alfa-2b (1)

Countries

Egypt (2)

Top investigators

Alaa Ismail, M.D. (1)  ·  Amal Abdel Baky, M.D. (1)  ·  Amany Sayed Ahmad, M.D. (1)  ·  Manal El Sayed, M.D. (1)  ·  Nezam H Afdhal, M.D. (1)  ·  Samer El Kamary (1)  ·  Sanaa M Kamal, M.D. (1)  ·  Sanaa M Kamal, M.D.; Ph.D (1)

Results publications

PMID 17943989